<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Infantile hypertrophic pyloric stenosis</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Infantile hypertrophic pyloric stenosis</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Infantile hypertrophic pyloric stenosis</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Authors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Erin E Endom, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Scott R Dorfman, MD</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Anthony P Olivé, MD</a></dd><dt><span> </span>Section Editors:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Joshua Nagler, MD, MHPEd</a></dd><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">B UK Li, MD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Alison G Hoppin, MD</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> Jan 27, 2023.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Infantile hypertrophic pyloric stenosis (IHPS) is a disorder of young infants caused by hypertrophy of the pylorus, which can progress to near-complete obstruction of the gastric outlet, leading to forceful vomiting.</p><p>The clinical manifestations, diagnosis, and treatment of IHPS are discussed below. The differential diagnosis of vomiting in infants and other related content are discussed separately. (See  <a class="medical medical_review" href="/d/html/5902.html" rel="external">"Approach to the infant or child with nausea and vomiting"</a> and  <a class="medical medical_review" href="/d/html/94562.html" rel="external">"Anesthesia for pyloromyotomy in infants"</a>.)</p><p class="headingAnchor" id="H17026470"><span class="h1">EPIDEMIOLOGY</span><span class="headingEndMark"> — </span>IHPS usually develops between three and five weeks of age and very rarely occurs after 12 weeks of age [<a href="#rid1">1</a>]. A trend toward earlier diagnosis was illustrated in a study comparing the presentation of a total of 283 infants diagnosed in the decades prior to 1975, 1985, and 1995 [<a href="#rid2">2</a>]. The mean age at presentation was significantly younger in the more recent decades (mean age 5.4 weeks in 1975 versus 3.4 weeks in 1995) [<a href="#rid3">3</a>]. The earlier diagnosis of IHPS might be explained by advances in diagnostic imaging or by increased awareness of the disorder among clinicians.</p><p>The condition occurs in approximately 1 to 3.5 per 1000 live births, although rates and trends vary markedly from region to region [<a href="#rid4">4-10</a>]. Several reports from resource-abundant countries suggest a declining incidence, with variable rates [<a href="#rid5">5,8,9,11</a>].</p><p>The incidence of IHPS is associated with:</p><p class="bulletIndent1"><span class="glyph">●</span>Male sex – Male:female ratio approximately 5:1 (prevalence ratio [PR] 5.0) [<a href="#rid4">4,7-9</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Preterm birth – PR approximately 1.4 for gestational age &lt;37 weeks [<a href="#rid8">8,12-15</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>First born – PR 1.3 to 1.5 for first born compared with later birth order [<a href="#rid8">8,12</a>]</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Younger maternal age – PR approximately 1.3 for mothers &lt;20 years, 1 for those 20 to &lt;35 years, and 0.8 for those ≥35 years [<a href="#rid8">8</a>]</p><p></p><p class="headingAnchor" id="H2"><span class="h1">PATHOGENESIS</span><span class="headingEndMark"> — </span>The etiology of IHPS is unclear but probably multifactorial, involving genetic predisposition and environmental factors [<a href="#rid16">16</a>].</p><p class="headingAnchor" id="H1052123529"><span class="h2">Macrolide antibiotics</span><span class="headingEndMark"> — </span>Both <a class="drug drug_pediatric" data-topicid="13276" href="/d/drug information/13276.html" rel="external">erythromycin</a> and <a class="drug drug_pediatric" data-topicid="12937" href="/d/drug information/12937.html" rel="external">azithromycin</a> are associated with increased risk of IHPS, particularly when administered to infants younger than two weeks of age [<a href="#rid17">17-23</a>]. The risk of IHPS with <a class="drug drug_pediatric" data-topicid="13165" href="/d/drug information/13165.html" rel="external">clarithromycin</a> is not known [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/d/html/5997.html" rel="external">"Pertussis infection in infants and children: Treatment and prevention", section on 'Choice of regimen'</a>.)</p><p>In a retrospective cohort of more than 1 million infants younger than 90 days, the overall rate of IHPS was 2.29 per 1000 [<a href="#rid17">17</a>]. The risk of IHPS varied with the age of exposure to <a class="drug drug_pediatric" data-topicid="12937" href="/d/drug information/12937.html" rel="external">azithromycin</a> or <a class="drug drug_pediatric" data-topicid="13276" href="/d/drug information/13276.html" rel="external">erythromycin</a>, as follows:</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="12937" href="/d/drug information/12937.html" rel="external">Azithromycin</a> prescribed at age 0 to 14 days – Adjusted OR (aOR) 8.3, 95% CI 2.6-26.0</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="12937" href="/d/drug information/12937.html" rel="external">Azithromycin</a> prescribed at age 15 to 42 days – aOR 3, 95% CI 1.2-7.2</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13276" href="/d/drug information/13276.html" rel="external">Erythromycin</a> prescribed at age 0 to 14 days – aOR 13.3, 95% CI 6.8-15.9</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_pediatric" data-topicid="13276" href="/d/drug information/13276.html" rel="external">Erythromycin</a> prescribed at age 15 to 42 days – aOR 4.1, 95% CI 1.7-9.9</p><p></p><p>A possible association between the use of macrolide antibiotics during late pregnancy or while breastfeeding and the development of IHPS in offspring has been suggested [<a href="#rid23">23,25-27</a>] but is not supported by a meta-analysis [<a href="#rid18">18</a>].</p><p>Cases of IHPS after the use of oral macrolide antibiotics should be reported to the US Food and Drug Administration safety information and adverse event reporting program (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.fda.gov%2Fsafety%2Fmedwatch-fda-safety-information-and-adverse-event-reporting-program&amp;token=xvyaImDcLZQw%2FKZaoXWwxUDhBq6SPMBQbzrmFLdvw6uLInTYq0WEZZE23nYfEJdpji3bziSW87ksfkpGSKeZ%2FC4BVOKV%2FWdosDZdfOoBdep7W5s6oZowZkx4dccnetNU&amp;TOPIC_ID=5890" target="_blank">MedWatch</a>).</p><p class="headingAnchor" id="H419243025"><span class="h2">Other environmental factors</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Smoking</strong> – Maternal smoking during pregnancy increases the risk for IHPS by 1.5- to 2-fold [<a href="#rid12">12,13,28-30</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bottle feeding</strong> – Bottle feeding is associated with increased risk for IHPS [<a href="#rid14">14,28,31-35</a>]. As an example, a large population-based study from Denmark found that bottle feeding during the first four months of life was associated with a more than fourfold increase in risk for IHPS (hazard ratio 4.62, 95% CI 2.78-7.65); a similar increase in risk was seen for infants that were both bottle- and breastfed [<a href="#rid33">33</a>]. In bottle-fed infants, similar risks were also seen in those who were never breastfed compared with those who had been formerly breastfed.</p><p></p><p class="headingAnchor" id="H32312292"><span class="h2">Genetic factors</span><span class="headingEndMark"> — </span>Approximately 6 percent of siblings of an affected patient develop IHPS; this is approximately 30 times the rate of the general population [<a href="#rid16">16</a>].</p><p>Familial aggregation of IHPS was examined in a large population registry from Denmark, in which the rate was nearly 200-fold higher among monozygotic twins and 20-fold higher among dizygotic twins or siblings compared with individuals with no affected relatives [<a href="#rid7">7</a>]. Heritability estimates from this and one other study are 87 and 30 percent, respectively [<a href="#rid7">7,36</a>]. The maternal and paternal contributions to heritability were similar, suggesting that the intrauterine environment was not an important causal factor.</p><p>Genome-wide association studies have identified several genetic loci that confer a predisposition to IHPS, possibly implicating genes involved in lipid metabolism (eg, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F107680&amp;token=tEpDslnpc0F0kICl%2Fz7sFc8JblQ%2BgdQqT9K%2Br8tS8tiC%2BVU5Td%2BuncnbTKGCF1rl&amp;TOPIC_ID=5890" target="_blank"><i>APOA1</i></a>), as well as several genes that are highly expressed in the stomach and involved in gastrointestinal tract development (<a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F607442&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyq5JKOL76CBJ86GKnhtglbm&amp;TOPIC_ID=5890" target="_blank"><i>EML4</i></a>, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F609050&amp;token=tEpDslnpc0F0kICl%2Fz7sFRE1gkgqgJF7T6niZxjpYaE275oWJmynPXsnR0pRHWzC&amp;TOPIC_ID=5890" target="_blank"><i>MTA3</i></a>, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F600584&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyrKnPRfO2suDlGsqsaho8UT&amp;TOPIC_ID=5890" target="_blank"><i>NKX2-5</i></a>, <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F603260&amp;token=tEpDslnpc0F0kICl%2Fz7sFUfdC7kgbt7z3sRDeh8bdyoz354q82koV7846yzlrhe7&amp;TOPIC_ID=5890" target="_blank"><i>BARX1</i></a>) [<a href="#rid36">36</a>].</p><p class="headingAnchor" id="H4"><span class="h1">CLINICAL MANIFESTATIONS</span></p><p class="headingAnchor" id="H1146396569"><span class="h2">Typical presentation</span><span class="headingEndMark"> — </span>IHPS typically presents with immediate postprandial vomiting in an infant between two and six weeks of age [<a href="#rid1">1</a>]. IHPS rarely presents after 12 weeks of age. A minority of infants present before two weeks of age, and these infants are more likely to have a positive family history of IHPS [<a href="#rid3">3</a>].</p><p>The vomiting is nonbilious and forceful ("projectile") or may become more forceful over time, with associated weight loss as symptoms progress. A minority develop electrolyte imbalances, particularly hypochloremia, due to loss of gastric hydrochloric acid [<a href="#rid37">37</a>]. The classically described "olive-like" mass in the right upper quadrant is not frequently appreciated on examination with early diagnosis of IHPS. Infants who are premature or who present very early tend to have more subtle signs and symptoms at presentation. (See <a class="local">'Atypical presentation'</a> below.)</p><p class="headingAnchor" id="H5"><span class="h2">Later presentation (classic)</span><span class="headingEndMark"> — </span>If the IHPS is not diagnosed and treated in the early stages, the condition usually persists and worsens. Thus, infants who are identified later in the disease course tend to have more severe symptoms, including marked weight loss and dehydration. Classically described features are an infant demanding to be refed soon after vomiting (a "hungry vomiter") and intestinal peristalsis visible through the thin abdominal wall. Infants with prolonged symptoms may have a hypochloremic, metabolic alkalosis due to the loss of large amounts of gastric hydrochloric acid, the severity of which depends on the duration of symptoms prior to evaluation [<a href="#rid38">38</a>]. Hypokalemia is also common in infants who have been vomiting for longer than three weeks but typically is not seen in those with a more recent onset of symptoms [<a href="#rid39">39</a>].</p><p>These classic symptoms were seen in a series of 132 infants who were diagnosed with IHPS in the 1970s, in which 91 percent presented with projectile vomiting after feedings [<a href="#rid40">40</a>]. In another review of infants diagnosed between 1957 and 1969, the mean age at which the infants began vomiting was 22 days [<a href="#rid41">41</a>]. In classic reports, the frequency of palpation of the pyloric "olive" typically was quite high (up to 92 percent in a report from 1975) [<a href="#rid40">40</a>] but has been noted to be less common in subsequent reports [<a href="#rid42">42-44</a>]. This change is probably due to increasing availability and reliance on ultrasound to make the diagnosis immediately upon suspicion, so that clinicians in the modern era have less practice at palpating the pyloric "olive" [<a href="#rid45">45</a>]. In addition, infants are now more likely to be evaluated earlier in the course of the disease, when they are well nourished, which makes palpation of the "olive" more difficult. (See <a class="local">'Abdominal examination'</a> below.)</p><p class="headingAnchor" id="H6"><span class="h2">Atypical presentation</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Premature infants</strong> – The presentation of IHPS in premature infants may be more subtle: The vomiting is less forceful, infants may lack the voracious appetite and exaggerated gastric peristalsis described in term infants, and the ultrasonographic criteria for diagnosis may not apply [<a href="#rid46">46-49</a>]. Premature infants may also present at an older chronologic age compared with term infants [<a href="#rid15">15,50</a>]. One study found a mean age at presentation of 7.6 weeks in infants born prior to 34 weeks gestation versus 5.4 weeks in term infants [<a href="#rid50">50</a>]. In hospitalized premature infants, nonprojectile vomiting, weight loss, and lethargy may initially be attributed to sepsis. (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Other infants</strong> – In addition to the presenting symptoms described above, the diagnosis of IHPS should be considered in young infants with repeated nonbilious vomiting, hypochloremic alkalosis, and/or rapid clinical improvement after rehydration, even in the absence of projectile vomiting or a palpable "olive" [<a href="#rid46">46,47</a>]. In a few infants with IHPS (&lt;2 percent), the vomiting may be bilious [<a href="#rid51">51</a>].</p><p></p><p class="bulletIndent1">In infants with other medical or surgical problems, the presentation may be atypical or the symptoms initially attributed to other etiologies. In infants with congenital anomalies that affect swallowing (eg, central nervous system anomalies, cleft lip and palate), vomiting may not be projectile [<a href="#rid46">46</a>]. In infants with gastrointestinal anomalies, postoperative vomiting may initially be attributed to adhesions or obstruction at an anastomotic site [<a href="#rid46">46</a>].</p><p></p><p class="headingAnchor" id="H7"><span class="h2">Clinical associations</span><span class="headingEndMark"> — </span>The following clinical associations with IHPS have been described:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hyperbilirubinemia</strong> – Hyperbilirubinemia is one of the most frequent clinical associations of IHPS (occurring in 14 percent of cases in one series [<a href="#rid52">52</a>]). The combination of IHPS and hyperbilirubinemia is known as the icteropyloric syndrome. Unconjugated hyperbilirubinemia is more common compared with conjugated hyperbilirubinemia; it is often related to the poor hydration and nutritional status of the presenting infant and tends to resolve soon after surgical intervention [<a href="#rid53">53</a>]. In some of these cases, the unconjugated hyperbilirubinemia is an early manifestation of Gilbert syndrome, a benign condition caused by mutations in the <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.omim.org%2Fentry%2F191740&amp;token=tEpDslnpc0F0kICl%2Fz7sFQdsXnRDd5WxpnJNX2h2G8P2L1%2Fe1eNlVntKQmsm%2B1Ie&amp;TOPIC_ID=5890" target="_blank"><i>UGT1A1</i></a> gene [<a href="#rid52">52,54</a>]. (See  <a class="medical medical_review" href="/d/html/5020.html" rel="external">"Unconjugated hyperbilirubinemia in neonates: Etiology and pathogenesis"</a> and  <a class="medical medical_review" href="/d/html/3578.html" rel="external">"Gilbert syndrome"</a> and <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1">If the hyperbilirubinemia is conjugated, other etiologies should be considered, including liver disease or sepsis. (See  <a class="medical medical_review" href="/d/html/5945.html" rel="external">"Causes of cholestasis in neonates and young infants"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Esophageal atresia</strong> – An association with esophageal atresia has been shown in several studies [<a href="#rid55">55-58</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Malrotation</strong> – Midgut malrotation has been described in 0.1 to 5 percent of infants with IHPS (a higher percentage than that of the general population), but it is unclear whether this is due to closer diagnostic surveillance [<a href="#rid55">55,59-61</a>]. A familial syndrome with malrotation, congenital short bowel, and IHPS also has been reported but is rare [<a href="#rid62">62-64</a>]. (See  <a class="medical medical_review" href="/d/html/6477.html" rel="external">"Intestinal malrotation in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Hypoplastic frenulum</strong> – Small case series have suggested a possible association between IHPS and an absent or hypoplastic mandibular frenulum, as well as joint hypermobility [<a href="#rid65">65,66</a>]. These minor abnormalities are not functionally significant but may provide clues to the pathogenesis of the disorder. Other small case series did not find such an association [<a href="#rid67">67</a>].</p><p></p><p>Other reported associations include hiatal hernia [<a href="#rid68">68</a>], diaphragmatic hernia [<a href="#rid61">61,69</a>], congenital heart disease [<a href="#rid55">55,61,70</a>], cleft lip and palate [<a href="#rid61">61</a>], obstructive defects of the urinary tract [<a href="#rid55">55</a>], propionic acidemia [<a href="#rid71">71</a>], congenital nephrotic syndrome [<a href="#rid72">72</a>], and congenital hypothyroidism [<a href="#rid73">73</a>]. A clinical picture of IHPS was described in a one-month-old infant with familial hyperlipidemia who had an intense hyperechogenicity of the thickened pyloric muscle on ultrasound and fatty infiltration of the pyloric muscle layer at surgical exploration [<a href="#rid74">74</a>]. The symptoms resolved after implementation of a fat-restricted diet.</p><p class="headingAnchor" id="H12171678"><span class="h1">EVALUATION</span></p><p class="headingAnchor" id="H12171761"><span class="h2">History</span><span class="headingEndMark"> — </span>The history should include details on:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Vomiting</strong> – Vomiting in IHPS is typically projectile (very forceful) and nonbilious and tends to occur immediately after feeding. The force and timing can help to distinguish IHPS from physiologic gastroesophageal reflux, in which most episodes of vomiting are not forceful and may occur 10 minutes or more after a meal. A history of bilious vomiting does not exclude IHPS but should raise concern about more distal intestinal obstruction, such as malrotation with volvulus or Hirschsprung disease.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Appetite</strong> – Classically, infants with IHPS have a strong appetite.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Urine output</strong> – Low urine output (four or fewer wet diapers daily) suggests dehydration.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Diet</strong> – Document the infant's diet and whether there were any changes prior to onset of symptoms. Vomiting that begins after a change in diet (eg, introduction of formula) or that is associated with diarrhea or bloody stools raises the possibility of a food allergy rather than IHPS. (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Medications</strong> – Exposure of the infant to macrolide antibiotics is an established risk factor for IHPS. (See <a class="local">'Macrolide antibiotics'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Exposures</strong> – Acute gastrointestinal symptoms in caregivers or contacts raise the possibility of an infectious process rather than IHPS.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Family history of IHPS</strong> – The risk of IHPS is substantially higher in infants with affected first-degree relatives. (See <a class="local">'Genetic factors'</a> above.)</p><p></p><p class="headingAnchor" id="H12171690"><span class="h2">Abdominal examination</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Auscultation and inspection</strong> – The abdomen should be evaluated for distension and bowel sounds. Peristaltic waves may be seen progressing across the child's upper abdomen from left to right just before emesis. Abdominal distension or high-pitched bowel sounds suggest intestinal obstruction (eg, stenosis or volvulus) rather than IHPS, especially if associated with bilious vomiting. Such infants should be evaluated promptly with abdominal radiographs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Palpation of the "olive"</strong> – Traditionally, the hypertrophied pylorus (known as the "olive") was palpable in 50 to 90 percent of infants with IHPS. When present, it is virtually pathognomonic of the disease (99 percent specificity in one study [<a href="#rid75">75</a>]).</p><p></p><p class="bulletIndent1">The hypertrophied pylorus is felt as a firm mass at the lateral edge of the rectus abdominis muscle in the right upper quadrant of the abdomen, approximately the size and shape of an olive. To palpate it, the abdomen should be examined when the infant is quiet to avoid interference from tensed abdominal muscles; providing a pacifier dipped in a <a class="drug drug_pediatric" data-topicid="16103" href="/d/drug information/16103.html" rel="external">sucrose</a> solution may be helpful to quiet the infant during the examination. Ideally, the examination should be performed immediately after an episode of emesis because the mass is less likely to be obscured by a distended antrum. As an alternative, the gastric contents can be emptied with a nasogastric tube, which helps to decompress the distended stomach and enhances the palpability of the pyloric mass.</p><p></p><p class="bulletIndent1">If the "olive" is palpated, some surgeons will proceed directly to surgery, without further testing. However, in the current era, the diagnosis of IHPS is typically made or confirmed by ultrasonography. Consequently, this sign is now identified in fewer than one-third of cases [<a href="#rid43">43,44</a>].</p><p></p><p class="headingAnchor" id="H12171754"><span class="h2">Other physical findings</span><span class="headingEndMark"> — </span>The infant should also be assessed for the following physical findings to evaluate for complications and help exclude disorders that can cause symptoms similar to IHPS:</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Weight and length</strong> – Measure weight and length to assess nutritional status, especially if the infant has had prolonged vomiting. When serial growth points are available, plotting them on a growth chart helps to establish whether there has been chronic or acute growth failure.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Mucous membranes and skin turgor</strong> – To assess hydration.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Skin and sclerae</strong> – Inspect for jaundice, which occurs in patients with IHPS and icteropyloric syndrome but also raises the possibility of underlying liver disease. The presence of eczema raises suspicion for a food allergy. (See <a class="local">'Clinical associations'</a> above and <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Stool</strong> – A stool should be visually inspected for mucus and blood and tested for occult blood. Rectal bleeding raises the possibility of cow's milk protein intolerance in a healthy-appearing infant or of intussusception in an unwell infant. Marked diarrhea raises the possibility of certain types of food allergy or infectious process (gastroenteritis). (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Genitalia</strong> – Assess for atypical genital appearance or other anomalies. Congenital adrenal hyperplasia (CAH) can present in the neonatal period with adrenal crisis, which can present with vomiting. CAH is associated with virilization of the genitalia in female infants but not in males. (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="headingAnchor" id="H12171779"><span class="h2">Laboratory testing</span><span class="headingEndMark"> — </span>In most infants with suspected IHPS, and especially in those who are ill-appearing, basic laboratory testing is appropriate to assess for dehydration and electrolyte depletion. At a minimum, the evaluation should include an electrolyte panel and complete blood count (CBC).</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Electrolytes</strong> – Interpretation is as follows:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Normal – Patients with recent onset of symptomatic IHPS usually have normal laboratory results.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Hypochloremic alkalosis – Low serum chloride and potassium and elevated bicarbonate are common in infants with prolonged symptoms due to IHPS. Either hypernatremia or hyponatremia may be present. One study showed that serum pH &gt;7.45, chloride &lt;98, and base excess &gt;+3 gave a positive predictive value of 88 percent in diagnosing IHPS in infants presenting with vomiting [<a href="#rid76">76</a>].</p><p></p><p class="bulletIndent2">By contrast, elevated serum potassium with low bicarbonate is <strong>not</strong> consistent with IHPS; infants with this finding should be urgently evaluated for other causes, including adrenal crisis (eg, CAH). (See <a class="local">'Differential diagnosis'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Blood urea nitrogen (BUN) and creatinine</strong> – These tests help to assess for dehydration and renal insufficiency (eg, prerenal azotemia due to dehydration). Because infants normally have lower serum creatinine values compared with older children, their BUN:creatinine ratio is higher; Therefore, a BUN:creatinine ratio &gt;20 in an infant is not a useful indicator of dehydration. (See  <a class="medical medical_review" href="/d/html/4989.html" rel="external">"Neonatal acute kidney injury: Pathogenesis, etiology, clinical presentation, and diagnosis"</a> and  <a class="medical medical_review" href="/d/html/6142.html" rel="external">"Clinical assessment of hypovolemia (dehydration) in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>CBC</strong> – The CBC is usually normal in infants with uncomplicated IHPS. Abnormal results do not exclude IHPS but should raise suspicion of another cause of vomiting (eg, infection).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Bilirubin</strong> – Infants with jaundice should be evaluated for total and conjugated bilirubin, aspartate aminotransferase (AST), alanine aminotransferase (ALT), and alkaline phosphatase or gamma-glutamyl transpeptidase (GGTP).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Elevated unconjugated bilirubin without other abnormalities is consistent with IHPS (see <a class="local">'Clinical associations'</a> above)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Elevations in conjugated bilirubin, ALT, or AST are not consistent with IHPS and warrant further evaluation for underlying liver disease (see <a class="local">'Differential diagnosis'</a> below)</p><p></p><p>Infants who are severely dehydrated or ill-appearing may warrant further evaluation to rule out other causes including sepsis, intestinal obstruction, or a primary metabolic disorder. (See  <a class="medical medical_review" href="/d/html/5043.html" rel="external">"Clinical features, evaluation, and diagnosis of sepsis in term and late preterm neonates"</a>.)</p><p class="headingAnchor" id="H12171545"><span class="h2">Imaging</span><span class="headingEndMark"> — </span>For infants with new onset of nonbilious vomiting who are between two weeks and three months of age, with typical clinical features of IHPS, ultrasound is recommended as the first imaging modality. Plain radiographs have limited utility but can show a dilated stomach, a nonspecific finding  (<a class="graphic graphic_diagnosticimage graphicRef139674" href="/d/graphic/139674.html" rel="external">image 1</a>). For infants with bilious vomiting, a fluoroscopic upper gastrointestinal (UGI) study may be needed to evaluate for or confirm a diagnosis of malrotation with midgut volvulus (although advances in ultrasonography may allow for evaluation of these conditions). Imaging strategies for infants with vomiting are detailed by the American College of Radiology <a class="external" href="/external-redirect?target_url=https%3A%2F%2Facsearch.acr.org%2Fdocs%2F69445%2FNarrative%2F&amp;token=f6IRefqoc19TgkACOU4NLcR2BzxM6YTKJe6BTzgxHue7mJa8aBzzSXxuv7Uud0acyxa1vMbs3b4VPgWsROg6dA%3D%3D&amp;TOPIC_ID=5890" target="_blank">Appropriateness Criteria</a> for infants.</p><p class="headingAnchor" id="H9"><span class="h3">Ultrasonography</span><span class="headingEndMark"> — </span>Ultrasound is the preferred imaging modality for suspected IHPS. Unlike radiography, ultrasound allows for the direct visualization of the pyloric muscle and canal and also has the benefit of lack of ionizing radiation. In the hands of an experienced sonographer or radiologist, the sensitivity and specificity of ultrasonography for the diagnosis of IHPS approaches 100 percent [<a href="#rid77">77-79</a>].</p><p>The diagnosis of IHPS is based on measurements of thickness of the muscle and the length of the canal. The thickness of the muscle can be measured on a transverse view (the "target" sign  (<a class="graphic graphic_diagnosticimage graphicRef139671" href="/d/graphic/139671.html" rel="external">image 2</a>)) or in the sagittal plane  (<a class="graphic graphic_diagnosticimage graphicRef139672" href="/d/graphic/139672.html" rel="external">image 3</a>). A measurement above 3 mm is considered positive. The length of the pyloric canal above 18 mm also indicates IHPS [<a href="#rid79">79</a>]. The presence or absence of fluid passage across the pylorus is not a useful diagnostic sign. If the ultrasound is negative or equivocal but the clinical picture remains concerning for IHPS, a repeat pyloric ultrasound should be considered within a few days as muscle hypertrophy can develop quickly.</p><p>There are a few potential pitfalls with ultrasound. Pylorospasm can mimic IHPS with failure of relaxation of the muscle. This is rarely a diagnostic challenge in clinical practice, but if sonographic findings are equivocal, repeat imaging can be performed after 15 to 20 minutes. Another pitfall may be the inability to visualize the pylorus due to a large amount of air within the UGI tract. Administration of water and placement of the patient in the right lateral decubitus position can provide an improved acoustic window.</p><p>More recent ultrasound techniques include direct visualization of the superior mesenteric artery and vein and identification of the third portion of the duodenum as it courses between the aorta and superior mesenteric artery. Identification of these features of normal anatomy is highly accurate in evaluating for malrotation and/or midgut volvulus [<a href="#rid80">80,81</a>].</p><p class="headingAnchor" id="H10"><span class="h3">Fluoroscopic upper gastrointestinal series</span><span class="headingEndMark"> — </span>For infants with bilious vomiting, a UGI study is indicated to evaluate for intestinal malrotation and/or midgut volvulus.</p><p>Prior to the development and refinement of ultrasound, UGI was the imaging study of choice for IHPS. Fluoroscopy is less desirable due to the associated ionizing radiation and the lack of direct visualization of the pyloric muscle. If UGI is performed in an infant with IHPS, narrowing of the canal can be seen (the "string" sign) or pointing of the <a class="drug drug_pediatric" data-topicid="118048" href="/d/drug information/118048.html" rel="external">barium</a> at the pyloric canal (the "beak" sign)  (<a class="graphic graphic_diagnosticimage graphicRef139673" href="/d/graphic/139673.html" rel="external">image 4</a>). An impression on the gastric antrum from the hypertrophied muscle (the "shoulder" sign) can also be seen. Pylorospasm can mimic the findings of IHPS with a UGI, and a suspicious UGI should be confirmed with a pyloric ultrasound.</p><p class="headingAnchor" id="H11"><span class="h2">Upper endoscopy</span><span class="headingEndMark"> — </span>Upper endoscopy usually is reserved for patients in whom other imaging modalities are inconclusive (or if warranted to evaluate for another gastrointestinal disorder because of symptoms or signs that are atypical for IHPS). In infants with IHPS, the mucosa of the antrum and pylorus appear thickened [<a href="#rid82">82</a>]. Endoscopy is useful for obtaining tissue sample if eosinophilic gastritis is suspected, which can mimic IHPS.</p><p class="headingAnchor" id="H12171716"><span class="h1">DIAGNOSIS</span><span class="headingEndMark"> — </span>The diagnosis of IHPS is suspected when an infant presents with suggestive features, as described above. The diagnosis can be confirmed by palpation of an "olive" or by the presence of typical findings on imaging studies. In many centers, ultrasonography is performed to confirm the diagnosis of IHPS prior to surgery, even if an "olive" is palpated. (See <a class="local">'Evaluation'</a> above.)</p><p class="headingAnchor" id="H93341740"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>The differential diagnosis of vomiting in early infancy includes the following disorders  (<a class="graphic graphic_table graphicRef94332" href="/d/graphic/94332.html" rel="external">table 1</a>). In most cases, these are easily distinguished from IHPS by the history, physical examination, and/or initial laboratory tests. (See  <a class="medical medical_review" href="/d/html/5902.html" rel="external">"Approach to the infant or child with nausea and vomiting", section on 'Disorders primarily seen in neonates and young infants'</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastroesophageal reflux</strong> – Physiologic reflux in newborns and infants is common and is characterized by effortless regurgitation in an otherwise healthy infant (a "happy spitter"). The regurgitation may seem forceful at times. Physiologic reflux is not associated with electrolyte abnormalities, tends to be chronic rather than progressive, and rarely causes weight loss. (See  <a class="medical medical_review" href="/d/html/5876.html" rel="external">"Gastroesophageal reflux in infants"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Sepsis </strong>– In hospitalized premature infants, nonprojectile vomiting, weight loss, and lethargy could be manifestations of sepsis or IHPS. Clues to the diagnosis of IHPS rather than sepsis are negative cultures, rapid improvement with intravenous fluids, and metabolic alkalosis (rather than acidosis which is often seen in sepsis) [<a href="#rid46">46</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Food allergy</strong> – Several distinct gastrointestinal disorders in children are caused by immunologic reactions to dietary proteins. Considerations for an infant with vomiting include immunoglobulin E (IgE)-mediated food allergy, food protein-induced enterocolitis syndrome, food protein-induced enteropathy, and food protein-induced proctocolitis. Clinical features and distinguishing characteristics of these disorders are outlined separately. (See  <a class="medical medical_review" href="/d/html/2386.html" rel="external">"Milk allergy: Clinical features and diagnosis", section on 'Clinical features'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Gastric or duodenal inflammatory disease</strong> – Eosinophilic gastritis or peptic ulcers can cause gastric outlet obstruction that mimics the symptoms of IHPS [<a href="#rid83">83-88</a>]. These disorders are uncommon in young infants but have been reported. Suggestive findings are lack of pyloric muscle hypertrophy on ultrasound; the definitive diagnosis requires endoscopy.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Adrenal crisis</strong> – Newborn infants with adrenal insufficiency may present with an adrenal crisis, manifested by vomiting and dehydration. This is a life-threatening condition and should be evaluated and treated urgently. Key features of adrenal crisis are disproportionate hypotension and hyperkalemic acidosis (rather than the hypokalemic alkalosis typically seen in IHPS). The most common cause of adrenal insufficiency in infants is congenital adrenal hyperplasia (CAH). Females with CAH tend to have virilized or ambiguous genitalia; males usually have no obvious genital abnormalities. (See  <a class="medical medical_review" href="/d/html/5828.html" rel="external">"Clinical manifestations and diagnosis of adrenal insufficiency in children", section on 'Adrenal crisis'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Intestinal obstruction</strong> – Causes of intestinal obstruction in early infancy include malrotation (with or without volvulus), intussusception, congenital antral web, and Hirschsprung disease. Intestinal obstruction should be considered in infants with bilious vomiting and abdominal distension, especially if high-pitched bowel sounds or bloody stools are present. If intestinal obstruction is suspected, the specific diagnosis is often suggested by the patient's history and then confirmed with appropriate radiologic imaging, including a plain radiograph. (See  <a class="medical medical_review" href="/d/html/5902.html" rel="external">"Approach to the infant or child with nausea and vomiting", section on 'Intestinal obstruction'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Liver disease</strong> – Liver disease in infants may present with symptoms resembling IHPS, including vomiting, poor weight gain, and jaundice. Infants with biliary atresia also may have acholic (very pale-colored) stools. Infants with conjugated hyperbilirubinemia should be further evaluated for liver disease, including biliary atresia, biliary cysts, and metabolic disorders. (See  <a class="medical medical_review" href="/d/html/5945.html" rel="external">"Causes of cholestasis in neonates and young infants"</a> and  <a class="medical medical_review" href="/d/html/5941.html" rel="external">"Approach to evaluation of cholestasis in neonates and young infants"</a>.)</p><p></p><p class="bulletIndent1">Evaluation of isolated elevated unconjugated bilirubin in a young infant is discussed separately. (See  <a class="medical medical_review" href="/d/html/5947.html" rel="external">"Evaluation of jaundice caused by unconjugated hyperbilirubinemia in children"</a>.)</p><p></p><p class="headingAnchor" id="H13"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>Definitive management of IHPS is surgical pyloromyotomy. The timing of surgery depends on the clinical status of the infant. If the child is well hydrated with normal electrolytes, and if surgeons with expertise in the procedure are available, surgery may take place on the day of diagnosis [<a href="#rid89">89</a>]. Surgery should be delayed in the setting of dehydration and/or electrolyte derangements [<a href="#rid90">90</a>].</p><p class="headingAnchor" id="H2290075917"><span class="h2">Preoperative fluid and electrolyte management</span><span class="headingEndMark"> — </span>Fluid and electrolyte therapy should be individualized according to the degree of dehydration and/or electrolyte abnormalities.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Normal electrolytes with mild or no dehydration</strong> – Infants presenting with normal electrolyte values and mild or no dehydration, as is the case with &gt;60 percent of patients, should receive maintenance intravenous fluids. (See  <a class="medical medical_review" href="/d/html/6122.html" rel="external">"Maintenance intravenous fluid therapy in children"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Moderate or severe dehydration</strong> – Infants with moderate or severe dehydration require more intensive management by administering isotonic fluids (typically normal <a class="drug drug_pediatric" data-topicid="12796" href="/d/drug information/12796.html" rel="external">saline</a> [0.9% NaCl]), given as an initial fluid bolus and/or higher rates of administration (1.5 to 2 times maintenance) until the calculated fluid deficit is repleted, followed by maintenance intravenous fluids. Renal function should be assessed before adding potassium to the intravenous fluids. (See  <a class="medical medical_review" href="/d/html/6103.html" rel="external">"Treatment of hypovolemia (dehydration) in children in resource-abundant settings"</a>.)</p><p></p><p class="bulletIndent1">We suggest the following targets for fluid and electrolyte therapy prior to undergoing surgery, as recommended by an expert panel [<a href="#rid91">91</a>]:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>pH ≤7.45 and/or base excess ≤3.5</p><p class="bulletIndent2"><span class="glyph">•</span>Bicarbonate &lt;26 mEq/L</p><p class="bulletIndent2"><span class="glyph">•</span>Sodium ≥132 mEq/L</p><p class="bulletIndent2"><span class="glyph">•</span>Potassium ≥3.5 mEq/L</p><p class="bulletIndent2"><span class="glyph">•</span>Chloride ≥100 mEq/L</p><p class="bulletIndent2"><span class="glyph">•</span>Glucose ≥72 mg/dL (4.0 mmol/L)</p><p></p><p class="bulletIndent1">Infants with significant alkalosis at the time of surgery are at increased risk of postoperative apnea [<a href="#rid92">92,93</a>]. Patients with severe hypokalemia (serum potassium &lt;2.5 mEq/L) or hyponatremia (serum sodium &lt;120 mEq/L) are at particularly high risk for perioperative complications and should be managed carefully, with expert consultation if needed. (See  <a class="medical medical_review" href="/d/html/97159.html" rel="external">"Hypokalemia in children"</a> and  <a class="medical medical_review" href="/d/html/120083.html" rel="external">"Hyponatremia in children: Evaluation and management"</a>.)</p><p></p><p class="headingAnchor" id="H17026729"><span class="h2">Pyloromyotomy</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Technique</strong> – The classical operation for IHPS is Ramstedt pyloromyotomy, which involves a longitudinal incision of the hypertrophic pylorus with blunt dissection to the level of the submucosa; it relieves the constriction and allows normal passage of stomach contents into the duodenum. Laparoscopic pyloromyotomy  (<a class="graphic graphic_picture graphicRef74120" href="/d/graphic/74120.html" rel="external">picture 1</a>) is a minimally invasive version of the Ramstedt procedure. In settings where appropriately trained surgical expertise is available, we suggest laparoscopic pyloromyotomy rather than the open procedure. Laparoscopic pyloromyotomy is associated with a lower incidence of postoperative emesis, reduced need for analgesia, and shorter hospital stay; however, it can rarely result in incomplete pyloromyotomy or mucosal perforation [<a href="#rid94">94-97</a>]. A transumbilical approach also may be used but has longer operating time [<a href="#rid98">98</a>].</p><p></p><p class="bulletIndent1">Open and laparoscopic pyloromyotomy were compared in a prospective randomized trial in 200 infants with ultrasonographically confirmed IHPS [<a href="#rid94">94</a>]. Both groups had similar operating time, time to full feeding, and hospital length of stay. However, infants in the laparoscopic group had fewer episodes of emesis (1.9 versus 2.6) and received fewer doses of analgesia (1.6 versus 2.2) compared with those in the open group. A similar randomized study also reported more rapid return to enteral feeding and shorter hospital stay among infants treated laparoscopically, although in 3 percent of laparoscopically performed cases, the pyloromyotomy was incomplete [<a href="#rid95">95</a>]. The study was performed at six centers with extensive experience in laparoscopic techniques.</p><p></p><p class="bulletIndent1">Anesthesia for pyloromyotomy is discussed separately. (See  <a class="medical medical_review" href="/d/html/94562.html" rel="external">"Anesthesia for pyloromyotomy in infants"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Resuming feeds postoperatively</strong> – For most infants, we suggest resuming ad lib feeding early (within a few hours) after surgery rather than delaying feeding and slowly advancing. Modest regurgitation occurs in as many as 80 percent of infants after pyloromyotomy [<a href="#rid40">40</a>] and should not delay feedings. Anticipatory guidance for the parent(s) to expect some postoperative regurgitation is helpful. The typical criterium for discharge readiness is that the infant tolerates at least 2 ounces (60 mL) of formula in two sequential feeds. Most infants are ready for discharge on postoperative day 1.</p><p></p><p class="bulletIndent1">Vigorous postoperative vomiting is infrequent. If vomiting persists beyond five days postoperatively, radiologic evaluation should be considered [<a href="#rid99">99</a>], with the understanding that interpretation of the study may be difficult because of postoperative swelling.</p><p></p><p class="bulletIndent1">The practice of resuming ad lib feeds in the early postoperative setting is supported by observational studies, clinical trials, and meta-analyses [<a href="#rid100">100-102</a>]. The meta-analysis included 14 studies (11 observational studies and 3 randomized trials) and concluded that ad lib feeding was associated with shorter duration of hospitalization compared with structured feeding (mean difference 4.7 days, 95% CI 1-8.4 days) [<a href="#rid100">100</a>]. In the four included studies examining early versus late feeding, early feeding was associated with a greater likelihood of postoperative emesis (odds ratio 3.1, 95% CI 2.3-4.4), but the duration of hospitalization was shorter (mean difference 12 hours); however, the latter finding was not statistically significant (95% CI 8 hours longer to 32 hours shorter).</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Postoperative monitoring</strong> – Infants with IHPS are at risk for apnea postoperatively because of their young age and effects of anesthesia; we suggest monitoring for apnea for at least 24 hours postoperatively. Those with underlying alkalosis may be at increased risk, based on limited and inferential data [<a href="#rid93">93</a>]. As mentioned above, this is one reason why alkalosis and other electrolyte abnormalities should be corrected prior to surgery.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Complications</strong> – The rate of serious complications from pyloromyotomy is low. Mucosal perforations occur in &lt;1 percent of patients and are readily recognized intraoperatively [<a href="#rid103">103</a>]. The pyloromyotomy is incomplete in approximately 1 to 3 percent of patients treated with a laparoscopic approach by an experienced surgeon and is even rarer in those undergoing the open procedure [<a href="#rid94">94,95,103</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Follow-up</strong> – Infants should be monitored through surgical recovery and return to normal feeds. Thereafter, they need only routine pediatric care, including monitoring of growth, unless new symptoms develop. Infants with other persistent or recurrent symptoms warrant further evaluation, including for disorders other than IHPS. If abdominal ultrasonography is performed postoperatively, caution should be exercised in interpretation because the thickened muscle and enlarged diameter persist to eight months and one year, respectively [<a href="#rid104">104</a>].</p><p></p><p class="headingAnchor" id="H2103248"><span class="h2">Other approaches (not recommended)</span><span class="headingEndMark"> — </span>Because surgery is both safe and effective, alternative approaches to managing IHPS are generally limited to infants with very high surgical risks or situations where pediatric surgical care is not available.</p><p class="bulletIndent1"><span class="glyph">●</span><strong>Atropine</strong> – Treatment with intravenous and/or oral <a class="drug drug_pediatric" data-topicid="12875" href="/d/drug information/12875.html" rel="external">atropine</a> sulfate (which relaxes the pyloric musculature) has been described in small observational studies [<a href="#rid105">105-108</a>] and two meta-analyses [<a href="#rid109">109,110</a>]. In a meta-analysis, the pooled success rate using atropine was 79 percent [<a href="#rid110">110</a>]. However, this approach typically requires weeks or months of atropine with parenteral nutrition or postpyloric enteral feeds, as well as prolonged hospital stay [<a href="#rid110">110,111</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Conservative management</strong> – Conservative management of infants with IHPS has also been described. This approach typically involves a trial of continuous nasoduodenal feedings, generally lasting several months, until the gastric outlet obstruction diminishes as the infant grows [<a href="#rid112">112</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Balloon dilation</strong> – Endoscopically guided balloon dilation for IHPS has been described [<a href="#rid113">113</a>]. However, balloon dilatation does not reliably disrupt the seromuscular ring of the pylorus and is associated with a significant risk of pyloric perforation [<a href="#rid114">114</a>].</p><p></p><p class="headingAnchor" id="H1256633003"><span class="h1">OUTCOMES</span><span class="headingEndMark"> — </span>Pyloromyotomy is curative in the vast majority of infants [<a href="#rid103">103</a>]. Gastroesophageal reflux in patients previously treated for IPHS is common, as it is in other healthy infants, and does not warrant concern unless it is very severe or accompanied by other symptoms. (See  <a class="medical medical_review" href="/d/html/5876.html" rel="external">"Gastroesophageal reflux in infants"</a>.)</p><p>In long-term follow-up, individuals who underwent pyloromyotomy as infants had no clinically significant differences in gastroesophageal reflux or other gastrointestinal symptoms during adulthood compared with age- and sex-matched controls [<a href="#rid115">115</a>]. Similarly, most studies show normal gastric emptying despite altered pyloric tone and motility in long-term follow-up [<a href="#rid116">116</a>].</p><p class="headingAnchor" id="H10123494"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.)</p><p class="bulletIndent1"><span class="glyph">●</span>Basics topic (see  <a class="medical medical_basics" href="/d/html/17115.html" rel="external">"Patient education: Pyloric stenosis in babies (The Basics)"</a>)</p><p></p><p class="headingAnchor" id="H17026477"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathogenesis</strong> – Infantile hypertrophic pyloric stenosis (IHPS) is characterized by hypertrophy of the pylorus, eventually progressing to near-complete obstruction of the gastric outlet. The etiology of IHPS is obscure but probably multifactorial, involving genetic predisposition and environmental factors. In particular, IHPS has been associated with the administration of macrolide antibiotics to infants during the first few weeks of life and perhaps to their mothers during late gestation or lactation. (See <a class="local">'Pathogenesis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Clinical presentation</strong> – Symptoms usually begin between three and five weeks of age and very rarely occur after 12 weeks of age. Typical presenting symptoms are nonbilious vomiting that is forceful and occurs immediately after feeding, while the infant remains hungry. In a small percentage of infants, the vomiting may be bilious. In premature infants with IHPS, the vomiting may be less forceful and they may not display hunger. A firm, "olive-like" mass is occasionally palpable in the right upper quadrant of the abdomen, and there may be signs of dehydration. (See <a class="local">'Clinical manifestations'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – Evaluation of an infant with suspected IHPS includes:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Physical examination</strong> – A firm, "olive-like" mass may be palpable in the right upper quadrant of the abdomen, and there may be signs of dehydration.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Laboratory testing</strong> – Measure electrolytes and complete blood count (CBC) to assess for dehydration and electrolyte depletion. Infants with IHPS may have normal results or may have low serum chloride and potassium and elevated bicarbonate (a hypochloremic alkalosis). (See <a class="local">'Laboratory testing'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Imaging</strong> – The diagnosis of IHPS is almost always confirmed by imaging, and ultrasonography is the modality of choice. Hallmarks of the diagnosis are increased thickness of the pyloric muscle and elongation of the pyloric canal  (<a class="graphic graphic_diagnosticimage graphicRef139672" href="/d/graphic/139672.html" rel="external">image 3</a>). For infants who present with bilious vomiting, a fluoroscopic upper gastrointestinal (UGI) study is indicated to evaluate for intestinal malrotation and/or midgut volvulus, although more recent advances in ultrasonography may allow for evaluation for these conditions. (See <a class="local">'Imaging'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Differential diagnosis</strong> – The differential diagnosis of IHPS includes physiologic gastroesophageal reflux and cow's milk protein intolerance, which are relatively benign. More severe disorders that may present with vomiting in the first two months of life include adrenal crisis, intestinal obstruction (eg, due to malrotation, Hirschsprung disease, or intussusception), and liver disease (eg, biliary atresia or metabolic defects). These disorders should be considered in infants with atypical presenting features, including hypotension, vomiting that is bilious, abdominal distension, or jaundice with conjugated hyperbilirubinemia  (<a class="graphic graphic_table graphicRef94332" href="/d/graphic/94332.html" rel="external">table 1</a>). (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Treatment</strong> – IHPS is treated surgically. (See <a class="local">'Pyloromyotomy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Timing of surgery</strong> – If the child is well hydrated with normal electrolytes, and if surgeons with expertise in the procedure are available, surgery may take place on the day of diagnosis.</p><p></p><p class="bulletIndent2">For infants with moderate to severe dehydration and/or electrolyte derangements, surgery should be delayed until these abnormalities are corrected. (See <a class="local">'Preoperative fluid and electrolyte management'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Surgical technique</strong> – In settings where appropriate surgical expertise is available, we suggest laparoscopic rather than open pyloromyotomy (<a class="grade" href="https://medilib.ir/uptodate/show/grade_5" rel="external">Grade 2B</a>). Laparoscopic pyloromyotomy is associated with a lower incidence of postoperative emesis, reduced need for analgesia, and shorter hospital stay. Complication rates are low with both procedures. (See <a class="local">'Pyloromyotomy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Postoperative feeds</strong> – For most infants, we suggest resuming ad lib feeding early (within a few hours) after surgery rather than delaying feeding and slowly advancing (<a class="grade" href="https://medilib.ir/uptodate/show/grade_6" rel="external">Grade 2C</a>). Feeds should not be delayed by mild regurgitation. (See <a class="local">'Pyloromyotomy'</a> above.)</p><p></p><p class="bulletIndent2"><span class="glyph">•</span><strong>Alternatives if surgery cannot be performed</strong> – Because surgery is both safe and effective, alternative approaches to managing IHPS are generally limited to infants with very high surgical risks or situations where pediatric surgical care is not available. Options include conservative management with nasoduodenal feeds, with or without <a class="drug drug_pediatric" data-topicid="12875" href="/d/drug information/12875.html" rel="external">atropine</a>. (See <a class="local">'Other approaches (not recommended)'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Aboagye J, Goldstein SD, Salazar JH, et al. Age at presentation of common pediatric surgical conditions: Reexamining dogma. J Pediatr Surg 2014; 49:995.</a></li><li><a class="nounderline abstract_t">Papadakis K, Chen EA, Luks FI, et al. The changing presentation of pyloric stenosis. Am J Emerg Med 1999; 17:67.</a></li><li><a class="nounderline abstract_t">Demian M, Nguyen S, Emil S. Early pyloric stenosis: a case control study. Pediatr Surg Int 2009; 25:1053.</a></li><li><a class="nounderline abstract_t">To T, Wajja A, Wales PW, Langer JC. Population demographic indicators associated with incidence of pyloric stenosis. Arch Pediatr Adolesc Med 2005; 159:520.</a></li><li><a class="nounderline abstract_t">Hedbäck G, Abrahamsson K, Husberg B, et al. The epidemiology of infantile hypertrophic pyloric stenosis in Sweden 1987-96. Arch Dis Child 2001; 85:379.</a></li><li><a class="nounderline abstract_t">Sommerfield T, Chalmers J, Youngson G, et al. The changing epidemiology of infantile hypertrophic pyloric stenosis in Scotland. Arch Dis Child 2008; 93:1007.</a></li><li><a class="nounderline abstract_t">Krogh C, Fischer TK, Skotte L, et al. Familial aggregation and heritability of pyloric stenosis. JAMA 2010; 303:2393.</a></li><li><a class="nounderline abstract_t">Kapoor R, Kancherla V, Cao Y, et al. Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States: A multistate, population-based retrospective study, 1999-2010. Birth Defects Res 2019; 111:159.</a></li><li><a class="nounderline abstract_t">Oetzmann von Sochaczewski C, Muensterer OJ. The incidence of infantile hypertrophic pyloric stenosis nearly halved from 2005 to 2017: analysis of German administrative data. Pediatr Surg Int 2021; 37:579.</a></li><li><a class="nounderline abstract_t">Donda K, Asare-Afriyie B, Ayensu M, et al. Pyloric Stenosis: National Trends in the Incidence Rate and Resource Use in the United States From 2012 to 2016. Hosp Pediatr 2019; 9:923.</a></li><li><a class="nounderline abstract_t">Yau A, Cha R, Jayaratnam S, et al. Declining incidence of pyloric stenosis in New Zealand. ANZ J Surg 2019; 89:1242.</a></li><li><a class="nounderline abstract_t">Krogh C, Gørtz S, Wohlfahrt J, et al. Pre- and perinatal risk factors for pyloric stenosis and their influence on the male predominance. Am J Epidemiol 2012; 176:24.</a></li><li><a class="nounderline abstract_t">Svenningsson A, Svensson T, Akre O, Nordenskjöld A. Maternal and pregnancy characteristics and risk of infantile hypertrophic pyloric stenosis. J Pediatr Surg 2014; 49:1226.</a></li><li><a class="nounderline abstract_t">Zhu J, Zhu T, Lin Z, et al. Perinatal risk factors for infantile hypertrophic pyloric stenosis: A meta-analysis. J Pediatr Surg 2017; 52:1389.</a></li><li><a class="nounderline abstract_t">Stark CM, Rogers PL, Eberly MD, Nylund CM. Association of prematurity with the development of infantile hypertrophic pyloric stenosis. Pediatr Res 2015; 78:218.</a></li><li><a class="nounderline abstract_t">MacMahon B. The continuing enigma of pyloric stenosis of infancy: a review. Epidemiology 2006; 17:195.</a></li><li><a class="nounderline abstract_t">Eberly MD, Eide MB, Thompson JL, Nylund CM. Azithromycin in early infancy and pyloric stenosis. Pediatrics 2015; 135:483.</a></li><li><a class="nounderline abstract_t">Abdellatif M, Ghozy S, Kamel MG, et al. Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis. Eur J Pediatr 2019; 178:301.</a></li><li><a class="nounderline abstract_t">Friedman DS, Curtis CR, Schauer SL, et al. Surveillance for transmission and antibiotic adverse events among neonates and adults exposed to a healthcare worker with pertussis. Infect Control Hosp Epidemiol 2004; 25:967.</a></li><li><a class="nounderline abstract_t">Honein MA, Paulozzi LJ, Himelright IM, et al. Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study. Lancet 1999; 354:2101.</a></li><li><a class="nounderline abstract_t">Centers for Disease Control and Prevention (CDC). Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999. MMWR Morb Mortal Wkly Rep 1999; 48:1117.</a></li><li><a class="nounderline abstract_t">Morrison W. Infantile hypertrophic pyloric stenosis in infants treated with azithromycin. Pediatr Infect Dis J 2007; 26:186.</a></li><li><a class="nounderline abstract_t">Lund M, Pasternak B, Davidsen RB, et al. Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study. BMJ 2014; 348:g1908.</a></li><li><a class="nounderline abstract_t">Hauben M, Amsden GW. The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental? Drug Saf 2002; 25:929.</a></li><li><a class="nounderline abstract_t">Mahon BE, Rosenman MB, Kleiman MB. Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis. J Pediatr 2001; 139:380.</a></li><li><a class="nounderline abstract_t">Cooper WO, Ray WA, Griffin MR. Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis. Obstet Gynecol 2002; 100:101.</a></li><li><a class="nounderline abstract_t">Sørensen HT, Skriver MV, Pedersen L, et al. Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides. Scand J Infect Dis 2003; 35:104.</a></li><li><a class="nounderline abstract_t">McAteer JP, Ledbetter DJ, Goldin AB. Role of bottle feeding in the etiology of hypertrophic pyloric stenosis. JAMA Pediatr 2013; 167:1143.</a></li><li><a class="nounderline abstract_t">Sørensen HT, Nørgård B, Pedersen L, et al. Maternal smoking and risk of hypertrophic infantile pyloric stenosis: 10 year population based cohort study. BMJ 2002; 325:1011.</a></li><li><a class="nounderline abstract_t">Boybeyi-Turer O, Çelik HT, Arslan UE, et al. Protocol: A systematic review and meta-analysis of the role of fetal and infantile environmental exposure in etiopathogenesis of infantile hypertrophic pyloric stenosis. PLoS One 2021; 16:e0247003.</a></li><li><a class="nounderline abstract_t">Pisacane A, de Luca U, Criscuolo L, et al. Breast feeding and hypertrophic pyloric stenosis: population based case-control study. BMJ 1996; 312:745.</a></li><li><a class="nounderline abstract_t">Habbick BF, Khanna C, To T. Infantile hypertrophic pyloric stenosis: a study of feeding practices and other possible causes. CMAJ 1989; 140:401.</a></li><li><a class="nounderline abstract_t">Krogh C, Biggar RJ, Fischer TK, et al. Bottle-feeding and the Risk of Pyloric Stenosis. Pediatrics 2012; 130:e943.</a></li><li><a class="nounderline abstract_t">Wayne C, Hung JH, Chan E, et al. Formula-feeding and hypertrophic pyloric stenosis: is there an association? A case-control study. J Pediatr Surg 2016; 51:779.</a></li><li><a class="nounderline abstract_t">Zvizdic Z, Halimic T, Milisic E, et al. Infantile hypertrophic pyloric stenosis in Bosnia and Herzegovina: A retrospective cohort study from the largest tertiary care facility. Asian J Surg 2022; 45:1694.</a></li><li><a class="nounderline abstract_t">Fadista J, Skotte L, Geller F, et al. Genome-wide meta-analysis identifies BARX1 and EML4-MTA3 as new loci associated with infantile hypertrophic pyloric stenosis. Hum Mol Genet 2019; 28:332.</a></li><li><a class="nounderline abstract_t">Taylor ND, Cass DT, Holland AJ. Infantile hypertrophic pyloric stenosis: has anything changed? J Paediatr Child Health 2013; 49:33.</a></li><li><a class="nounderline abstract_t">Touloukian RJ, Higgins E. The spectrum of serum electrolytes in hypertrophic pyloric stenosis. J Pediatr Surg 1983; 18:394.</a></li><li><a class="nounderline abstract_t">Nmadu PT. Alterations in serum electrolytes in congenital hypertrophic pyloric stenosis: a study in Nigerian children. Ann Trop Paediatr 1992; 12:169.</a></li><li><a class="nounderline abstract_t">Gibbs MK, Van Herrden JA, Lynn HB. Congenital hypertrophic pyloric stenosis. Surgical experience. Mayo Clin Proc 1975; 50:312.</a></li><li><a class="nounderline abstract_t">Dodge JA. Infantile hypertrophic pyloric stenosis in Belfast, 1957-1969. Arch Dis Child 1975; 50:171.</a></li><li><a class="nounderline abstract_t">Macdessi J, Oates RK. Clinical diagnosis of pyloric stenosis: a declining art. BMJ 1993; 306:553.</a></li><li><a class="nounderline abstract_t">Bakal U, Sarac M, Aydin M, et al. Recent changes in the features of hypertrophic pyloric stenosis. Pediatr Int 2016; 58:369.</a></li><li><a class="nounderline abstract_t">Glatstein M, Carbell G, Boddu SK, et al. The changing clinical presentation of hypertrophic pyloric stenosis: the experience of a large, tertiary care pediatric hospital. Clin Pediatr (Phila) 2011; 50:192.</a></li><li><a class="nounderline abstract_t">Shaoul R, Enav B, Steiner Z, et al. Clinical presentation of pyloric stenosis: the change is in our hands. Isr Med Assoc J 2004; 6:134.</a></li><li><a class="nounderline abstract_t">Weinstein MM, Seibert JJ, Erenberg A. Six atypical presentations of congenital hypertrophic pyloric stenosis. Clin Pediatr (Phila) 1979; 18:120.</a></li><li><a class="nounderline abstract_t">Janik JS, Wayne ER, Janik JP. Pyloric stenosis in premature infants. Arch Pediatr Adolesc Med 1996; 150:223.</a></li><li><a class="nounderline abstract_t">Cosman BC, Sudekum AE, Oakes DD, de Vries PA. Pyloric stenosis in a premature infant. J Pediatr Surg 1992; 27:1534.</a></li><li><a class="nounderline abstract_t">Bisset RA, Gupta SC. Hypertrophic pyloric stenosis, ultrasonic appearances in a small baby. Pediatr Radiol 1988; 18:405.</a></li><li><a class="nounderline abstract_t">Costanzo CM, Vinocur C, Berman L. Prematurity Affects Age of Presentation of Pyloric Stenosis. Clin Pediatr (Phila) 2017; 56:127.</a></li><li><a class="nounderline abstract_t">Piroutek MJ, Brown L, Thorp AW. Bilious vomiting does not rule out infantile hypertrophic pyloric stenosis. Clin Pediatr (Phila) 2012; 51:214.</a></li><li><a class="nounderline abstract_t">Hua L, Shi D, Bishop PR, et al. The role of UGT1A1*28 mutation in jaundiced infants with hypertrophic pyloric stenosis. Pediatr Res 2005; 58:881.</a></li><li><a class="nounderline abstract_t">Stringer MD, Brereton RJ. Current management of infantile hypertrophic pyloric stenosis. Br J Hosp Med 1990; 43:266.</a></li><li><a class="nounderline abstract_t">Trioche P, Chalas J, Francoual J, et al. Jaundice with hypertrophic pyloric stenosis as an early manifestation of Gilbert syndrome. Arch Dis Child 1999; 81:301.</a></li><li><a class="nounderline abstract_t">Applegate MS, Druschel CM. The epidemiology of infantile hypertrophic pyloric stenosis in New York State, 1983 to 1990. Arch Pediatr Adolesc Med 1995; 149:1123.</a></li><li><a class="nounderline abstract_t">van Beelen NW, Mous DS, Brosens E, et al. Increased incidence of hypertrophic pyloric stenosis in esophageal atresia patients. Eur J Pediatr Surg 2014; 24:20.</a></li><li><a class="nounderline abstract_t">Deurloo JA, Ekkelkamp S, Schoorl M, et al. Esophageal atresia: historical evolution of management and results in 371 patients. Ann Thorac Surg 2002; 73:267.</a></li><li><a class="nounderline abstract_t">Ten Kate CA, Brouwer RWW, van Bever Y, et al. Infantile hypertrophic pyloric stenosis in patients with esophageal atresia. Birth Defects Res 2020; 112:670.</a></li><li><a class="nounderline abstract_t">Zeidan B, Wyatt J, Mackersie A, Brereton RJ. Recent results of treatment of infantile hypertrophic pyloric stenosis. Arch Dis Child 1988; 63:1060.</a></li><li><a class="nounderline abstract_t">Croitoru D, Neilson I, Guttman FM. Pyloric stenosis associated with malrotation. J Pediatr Surg 1991; 26:1276.</a></li><li><a class="nounderline abstract_t">Schärli A, Sieber WK, Kiesewetter WB. Hypertrophic pyloric stenosis at the Children's Hospital of Pittsburgh from 1912 to 1967. A critical review of current problems and complications. J Pediatr Surg 1969; 4:108.</a></li><li><a class="nounderline abstract_t">Brereton RJ. Midgut malrotation associated with hypertrophic pyloric stenosis had concomitant congenital short bowel. J Pediatr Surg 1992; 27:796.</a></li><li><a class="nounderline abstract_t">Levin MD, Troian VV. [Combined malrotation of the intestines with pyloric stenosis in a 6-day-old infant]. Klin Khir 1984; :56.</a></li><li><a class="nounderline abstract_t">Sansaricq C, Chen WJ, Manka M, et al. Familial congenital short small bowel with associated defects. A long-term survival. Clin Pediatr (Phila) 1984; 23:453.</a></li><li><a class="nounderline abstract_t">De Felice C, Di Maggio G, Zagordo L, et al. Hypoplastic or absent mandibular frenulum: a new predictive sign of infantile hypertrophic pyloric stenosis. J Pediatr 2000; 136:408.</a></li><li><a class="nounderline abstract_t">De Felice C, Di Maggio G, Toti P, et al. Infantile hypertrophic pyloric stenosis and asymptomatic joint hypermobility. J Pediatr 2001; 138:596.</a></li><li><a class="nounderline abstract_t">Hochwald O, Shaoul R. The missing of missing mandibular frenulum in hypertrophic pyloric stenosis. J Pediatr Gastroenterol Nutr 2005; 40:101; author reply 100.</a></li><li><a class="nounderline abstract_t">Iijima T, Okamatsu T, Matsumura M, Yatsuzuka M. Hypertrophic pyloric stenosis associated with hiatal hernia. J Pediatr Surg 1996; 31:277.</a></li><li><a class="nounderline abstract_t">al-Salem AH, Grant C, Khwaja S. Infantile hypertrophic pyloric stenosis and congenital diaphragmatic hernia. J Pediatr Surg 1990; 25:607.</a></li><li><a class="nounderline abstract_t">Feenstra B, Gørtz S, Lund M, et al. Co-occurrence of infantile hypertrophic pyloric stenosis and congenital heart defects: a nationwide cohort study. Pediatr Res 2019; 85:955.</a></li><li><a class="nounderline abstract_t">Lehnert W, Junker A, Wehinger H, et al. [Propionic acidemia associated with hypertrophic pyloric stenosis and bouts of severe hyperglycemia (author's transl)]. Monatsschr Kinderheilkd 1980; 128:720.</a></li><li><a class="nounderline abstract_t">Grahame-Smith HN, Ward PS, Jones RD. Finnish type congenital nephrotic syndrome in twins: presentation with pyloric stenosis. J R Soc Med 1988; 81:358.</a></li><li><a class="nounderline abstract_t">Hirano T, Jogamoto M, Tamura K. Association of congenital hypothyroidism with congenital hypertrophic pyloric stenosis. Acta Paediatr Jpn 1988; 30:371.</a></li><li><a class="nounderline abstract_t">Veyrac C, Couture A, Bongrand AF, et al. Atypical pyloric stenosis in an infant with familial hyperlipidemia. Pediatr Radiol 1996; 26:402.</a></li><li><a class="nounderline abstract_t">White MC, Langer JC, Don S, DeBaun MR. Sensitivity and cost minimization analysis of radiology versus olive palpation for the diagnosis of hypertrophic pyloric stenosis. J Pediatr Surg 1998; 33:913.</a></li><li><a class="nounderline abstract_t">Oakley EA, Barnett PL. Is acid base determination an accurate predictor of pyloric stenosis? J Paediatr Child Health 2000; 36:587.</a></li><li><a class="nounderline abstract_t">Sivitz AB, Tejani C, Cohen SG. Evaluation of hypertrophic pyloric stenosis by pediatric emergency physician sonography. Acad Emerg Med 2013; 20:646.</a></li><li><a class="nounderline abstract_t">Niedzielski J, Kobielski A, Sokal J, Krakós M. Accuracy of sonographic criteria in the decision for surgical treatment in infantile hypertrophic pyloric stenosis. Arch Med Sci 2011; 7:508.</a></li><li><a class="nounderline abstract_t">Hernanz-Schulman M. Pyloric stenosis: role of imaging. Pediatr Radiol 2009; 39 Suppl 2:S134.</a></li><li><a class="nounderline abstract_t">Nguyen HN, Navarro OM, Guillerman RP, et al. Untwisting the complexity of midgut malrotation and volvulus ultrasound. Pediatr Radiol 2021; 51:658.</a></li><li><a class="nounderline abstract_t">Nguyen HN, Sammer MBK, Ditzler MG, et al. Transition to ultrasound as the first-line imaging modality for midgut volvulus: keys to a successful roll-out. Pediatr Radiol 2021; 51:506.</a></li><li><a class="nounderline abstract_t">Liacouras CA, Cook-Sather SD, Schreiner MS, Bellah RD. Endoscopic findings in hypertrophic pyloric stenosis: appearance in classic and evolving disease. Gastrointest Endosc 1997; 45:371.</a></li><li><a class="nounderline abstract_t">Blankenberg FG, Parker BR, Sibley E, Kerner JA. Evolving asymmetric hypertrophic pyloric stenosis associated with histologic evidence of eosinophilic gastroenteritis. Pediatr Radiol 1995; 25:310.</a></li><li><a class="nounderline abstract_t">Kelsey D, Stayman JW Jr, McLaughlin ED, Mebane W. Massive bleeding in a newborn infant from a gastric ulcer associated with hypertrophic pyloric stenosis. Surgery 1968; 64:979.</a></li><li><a class="nounderline abstract_t">Yokoyama S, Nakaoka T, Nukada T, et al. Neonatal eosinophilic gastroenteritis mimicking hypertrophic pyloric stenosis. Pediatr Int 2020; 62:99.</a></li><li><a class="nounderline abstract_t">Choi SJ, Jang YJ, Choe BH, et al. Eosinophilic gastritis with gastric outlet obstruction mimicking infantile hypertrophic pyloric stenosis. J Pediatr Gastroenterol Nutr 2014; 59:e9.</a></li><li><a class="nounderline abstract_t">MENDL K, JENKINS RT, PENLINGTON ER. Gastric ulcer in the newborn and its association with antral spasm resulting in hypertrophic pyloric stenosis. Br J Radiol 1962; 35:831.</a></li><li><a class="nounderline abstract_t">LEVINE M. Hypertrophic pyloric stenosis of infancy associated with ulcer. A case report. Arch Pediatr (N Y) 1961; 78:475.</a></li><li><a class="nounderline abstract_t">Poon TS, Zhang AL, Cartmill T, Cass DT. Changing patterns of diagnosis and treatment of infantile hypertrophic pyloric stenosis: a clinical audit of 303 patients. J Pediatr Surg 1996; 31:1611.</a></li><li><a class="nounderline abstract_t">Nakayama DK, Taylor LA. Hypertrophic pyloric stenosis in infancy. An analysis of treatment outcome. N C Med J 1998; 59:310.</a></li><li><a class="nounderline abstract_t">van den Bunder FAIM, Hall NJ, van Heurn LWE, Derikx JPM. A Delphi Analysis to Reach Consensus on Preoperative Care in Infants with Hypertrophic Pyloric Stenosis. Eur J Pediatr Surg 2020; 30:497.</a></li><li><a class="nounderline abstract_t">Steven IM, Allen TH, Sweeney DB. Congenital hypertrophic pyloric stenosis: the anaesthetist's view. Anaesth Intensive Care 1973; 1:544.</a></li><li><a class="nounderline abstract_t">Tigges CR, Bigham MT. Hypertrophic pyloric stenosis: it can take your breath away. Air Med J 2012; 31:45.</a></li><li><a class="nounderline abstract_t">St Peter SD, Holcomb GW 3rd, Calkins CM, et al. Open versus laparoscopic pyloromyotomy for pyloric stenosis: a prospective, randomized trial. Ann Surg 2006; 244:363.</a></li><li><a class="nounderline abstract_t">Hall NJ, Pacilli M, Eaton S, et al. Recovery after open versus laparoscopic pyloromyotomy for pyloric stenosis: a double-blind multicentre randomised controlled trial. Lancet 2009; 373:390.</a></li><li><a class="nounderline abstract_t">Siddiqui S, Heidel RE, Angel CA, Kennedy AP Jr. Pyloromyotomy: randomized control trial of laparoscopic vs open technique. J Pediatr Surg 2012; 47:93.</a></li><li><a class="nounderline abstract_t">Staerkle RF, Lunger F, Fink L, et al. Open versus laparoscopic pyloromyotomy for pyloric stenosis. Cochrane Database Syst Rev 2021; 3:CD012827.</a></li><li><a class="nounderline abstract_t">Kim SS, Lau ST, Lee SL, et al. Pyloromyotomy: a comparison of laparoscopic, circumumbilical, and right upper quadrant operative techniques. J Am Coll Surg 2005; 201:66.</a></li><li><a class="nounderline abstract_t">Hulka F, Harrison MW, Campbell TJ, Campbell JR. Complications of pyloromyotomy for infantile hypertrophic pyloric stenosis. Am J Surg 1997; 173:450.</a></li><li><a class="nounderline abstract_t">Sullivan KJ, Chan E, Vincent J, et al. Feeding Post-Pyloromyotomy: A Meta-analysis. Pediatrics 2016; 137.</a></li><li><a class="nounderline abstract_t">Hong Y, Okolo F, Morgan K, et al. Safety and benefit of ad libitum feeding following laparoscopic pyloromyotomy: retrospective comparative trial. Pediatr Surg Int 2022; 38:555.</a></li><li><a class="nounderline abstract_t">Adibe OO, Iqbal CW, Sharp SW, et al. Protocol versus ad libitum feeds after laparoscopic pyloromyotomy: a prospective randomized trial. J Pediatr Surg 2014; 49:129.</a></li><li><a class="nounderline abstract_t">Hall NJ, Eaton S, Seims A, et al. Risk of incomplete pyloromyotomy and mucosal perforation in open and laparoscopic pyloromyotomy. J Pediatr Surg 2014; 49:1083.</a></li><li><a class="nounderline abstract_t">Muramori K, Nagasaki A, Kawanami T. Ultrasonographic serial measurements of the morphologic resolution of the pylorus after Ramstedt pyloromyotomy for infantile hypertrophic pyloric stenosis. J Ultrasound Med 2007; 26:1681.</a></li><li><a class="nounderline abstract_t">Singh UK, Kumar R, Prasad R. Oral atropine sulfate for infantile hypertrophic pyloric stenosis. Indian Pediatr 2005; 42:473.</a></li><li><a class="nounderline abstract_t">Kawahara H, Takama Y, Yoshida H, et al. Medical treatment of infantile hypertrophic pyloric stenosis: should we always slice the "olive"? J Pediatr Surg 2005; 40:1848.</a></li><li><a class="nounderline abstract_t">Lukac M, Antunovic SS, Vujovic D, et al. Is abandonment of nonoperative management of hypertrophic pyloric stenosis warranted? Eur J Pediatr Surg 2013; 23:80.</a></li><li><a class="nounderline abstract_t">Mercer AE, Phillips R. Question 2: can a conservative approach to the treatment of hypertrophic pyloric stenosis with atropine be considered a real alternative to surgical pyloromyotomy? Arch Dis Child 2013; 98:474.</a></li><li><a class="nounderline abstract_t">Wu SF, Lin HY, Huang FK, et al. Efficacy of Medical Treatment for Infantile Hypertrophic Pyloric Stenosis: A Meta-analysis. Pediatr Neonatol 2016; 57:515.</a></li><li><a class="nounderline abstract_t">Lauriti G, Cascini V, Chiesa PL, et al. Atropine Treatment for Hypertrophic Pyloric Stenosis: A Systematic Review and Meta-Analysis. Eur J Pediatr Surg 2018; 28:393.</a></li><li><a class="nounderline abstract_t">Danko ME, Evans PT, Upperman JS. Current management of pyloric stenosis. Semin Pediatr Surg 2022; 31:151145.</a></li><li><a class="nounderline abstract_t">Yamashiro Y, Mayama H, Yamamoto K, et al. Conservative management of infantile pyloric stenosis by nasoduodenal feeding. Eur J Pediatr 1981; 136:187.</a></li><li><a class="nounderline abstract_t">Ogawa Y, Higashimoto Y, Nishijima E, et al. Successful endoscopic balloon dilatation for hypertrophic pyloric stenosis. J Pediatr Surg 1996; 31:1712.</a></li><li><a class="nounderline abstract_t">Hayashi AH, Giacomantonio JM, Lau HY, Gillis DA. Balloon catheter dilatation for hypertrophic pyloric stenosis. J Pediatr Surg 1990; 25:1119.</a></li><li><a class="nounderline abstract_t">Danielson J, Svenningsson A, Jansson P, Läckgren G. Controlled long term outcome of pyloromyotomy for pyloric stenosis: No long-term adverse effect. J Pediatr Surg 2022; 57:736.</a></li><li><a class="nounderline abstract_t">Sun WM, Doran SM, Jones KL, et al. Long-term effects of pyloromyotomy on pyloric motility and gastric emptying in humans. Am J Gastroenterol 2000; 95:92.</a></li></ol></div><div id="topicVersionRevision">Topic 5890 Version 42.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24888850" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Age at presentation of common pediatric surgical conditions: Reexamining dogma.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9928704" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : The changing presentation of pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19697044" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Early pyloric stenosis: a case control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15939849" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Population demographic indicators associated with incidence of pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11668097" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : The epidemiology of infantile hypertrophic pyloric stenosis in Sweden 1987-96.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18285388" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : The changing epidemiology of infantile hypertrophic pyloric stenosis in Scotland.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20551410" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Familial aggregation and heritability of pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30549250" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Prevalence and descriptive epidemiology of infantile hypertrophic pyloric stenosis in the United States: A multistate, population-based retrospective study, 1999-2010.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33469698" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : The incidence of infantile hypertrophic pyloric stenosis nearly halved from 2005 to 2017: analysis of German administrative data.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31748239" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Pyloric Stenosis: National Trends in the Incidence Rate and Resource Use in the United States From 2012 to 2016.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31450263" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Declining incidence of pyloric stenosis in New Zealand.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22553083" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Pre- and perinatal risk factors for pyloric stenosis and their influence on the male predominance.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25092081" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Maternal and pregnancy characteristics and risk of infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28318599" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Perinatal risk factors for infantile hypertrophic pyloric stenosis: A meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25950452" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Association of prematurity with the development of infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16477261" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : The continuing enigma of pyloric stenosis of infancy: a review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25687145" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Azithromycin in early infancy and pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30470884" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Association between exposure to macrolides and the development of infantile hypertrophic pyloric stenosis: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15566032" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Surveillance for transmission and antibiotic adverse events among neonates and adults exposed to a healthcare worker with pertussis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10609814" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Infantile hypertrophic pyloric stenosis after pertussis prophylaxis with erythromcyin: a case review and cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10634345" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Hypertrophic pyloric stenosis in infants following pertussis prophylaxis with erythromycin--Knoxville, Tennessee, 1999.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17259889" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Infantile hypertrophic pyloric stenosis in infants treated with azithromycin.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24618148" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : Use of macrolides in mother and child and risk of infantile hypertrophic pyloric stenosis: nationwide cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12381214" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : The association of erythromycin and infantile hypertrophic pyloric stenosis: causal or coincidental?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11562617" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Maternal and infant use of erythromycin and other macrolide antibiotics as risk factors for infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12100810" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Prenatal prescription of macrolide antibiotics and infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12693559" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Risk of infantile hypertrophic pyloric stenosis after maternal postnatal use of macrolides.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24146084" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Role of bottle feeding in the etiology of hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12411361" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Maternal smoking and risk of hypertrophic infantile pyloric stenosis: 10 year population based cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33592043" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Protocol: A systematic review and meta-analysis of the role of fetal and infantile environmental exposure in etiopathogenesis of infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8605461" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : Breast feeding and hypertrophic pyloric stenosis: population based case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2914261" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Infantile hypertrophic pyloric stenosis: a study of feeding practices and other possible causes.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22945411" id="rid32" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>33 : Bottle-feeding and the Risk of Pyloric Stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26944185" id="rid33" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>34 : Formula-feeding and hypertrophic pyloric stenosis: is there an association? A case-control study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/34801371" id="rid34" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>35 : Infantile hypertrophic pyloric stenosis in Bosnia and Herzegovina: A retrospective cohort study from the largest tertiary care facility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30281099" id="rid35" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>36 : Genome-wide meta-analysis identifies BARX1 and EML4-MTA3 as new loci associated with infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23198903" id="rid36" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>37 : Infantile hypertrophic pyloric stenosis: has anything changed?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6620080" id="rid37" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>38 : The spectrum of serum electrolytes in hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1381892" id="rid38" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>39 : Alterations in serum electrolytes in congenital hypertrophic pyloric stenosis: a study in Nigerian children.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1127996" id="rid39" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>40 : Congenital hypertrophic pyloric stenosis. Surgical experience.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1170811" id="rid40" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>41 : Infantile hypertrophic pyloric stenosis in Belfast, 1957-1969.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8461768" id="rid41" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>42 : Clinical diagnosis of pyloric stenosis: a declining art.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26615824" id="rid42" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>43 : Recent changes in the features of hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21098534" id="rid43" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>44 : The changing clinical presentation of hypertrophic pyloric stenosis: the experience of a large, tertiary care pediatric hospital.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15055266" id="rid44" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>45 : Clinical presentation of pyloric stenosis: the change is in our hands.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/761434" id="rid45" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>46 : Six atypical presentations of congenital hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8556133" id="rid46" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>47 : Pyloric stenosis in premature infants.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1469564" id="rid47" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>48 : Pyloric stenosis in a premature infant.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3174282" id="rid48" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>49 : Hypertrophic pyloric stenosis, ultrasonic appearances in a small baby.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27149987" id="rid49" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>50 : Prematurity Affects Age of Presentation of Pyloric Stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22166750" id="rid50" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>51 : Bilious vomiting does not rule out infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16257926" id="rid51" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>52 : The role of UGT1A1*28 mutation in jaundiced infants with hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2189519" id="rid52" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>53 : Current management of infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10490432" id="rid53" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>54 : Jaundice with hypertrophic pyloric stenosis as an early manifestation of Gilbert syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7550816" id="rid54" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>55 : The epidemiology of infantile hypertrophic pyloric stenosis in New York State, 1983 to 1990.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23982818" id="rid55" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>56 : Increased incidence of hypertrophic pyloric stenosis in esophageal atresia patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11834021" id="rid56" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>57 : Esophageal atresia: historical evolution of management and results in 371 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/32298054" id="rid57" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>58 : Infantile hypertrophic pyloric stenosis in patients with esophageal atresia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3178265" id="rid58" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>59 : Recent results of treatment of infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1812255" id="rid59" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>60 : Pyloric stenosis associated with malrotation.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5779275" id="rid60" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>61 : Hypertrophic pyloric stenosis at the Children's Hospital of Pittsburgh from 1912 to 1967. A critical review of current problems and complications.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/1501049" id="rid61" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>62 : Midgut malrotation associated with hypertrophic pyloric stenosis had concomitant congenital short bowel.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6471705" id="rid62" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>63 : [Combined malrotation of the intestines with pyloric stenosis in a 6-day-old infant].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6428792" id="rid63" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>64 : Familial congenital short small bowel with associated defects. A long-term survival.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10700703" id="rid64" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>65 : Hypoplastic or absent mandibular frenulum: a new predictive sign of infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11295730" id="rid65" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>66 : Infantile hypertrophic pyloric stenosis and asymptomatic joint hypermobility.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15625440" id="rid66" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>67 : The missing of missing mandibular frenulum in hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8938359" id="rid67" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>68 : Hypertrophic pyloric stenosis associated with hiatal hernia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2358993" id="rid68" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>69 : Infantile hypertrophic pyloric stenosis and congenital diaphragmatic hernia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/30862960" id="rid69" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>70 : Co-occurrence of infantile hypertrophic pyloric stenosis and congenital heart defects: a nationwide cohort study.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6110180" id="rid70" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>71 : [Propionic acidemia associated with hypertrophic pyloric stenosis and bouts of severe hyperglycemia (author's transl)].</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3404530" id="rid71" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>72 : Finnish type congenital nephrotic syndrome in twins: presentation with pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/3150224" id="rid72" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>73 : Association of congenital hypothyroidism with congenital hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8657477" id="rid73" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>74 : Atypical pyloric stenosis in an infant with familial hyperlipidemia.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9660228" id="rid74" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>75 : Sensitivity and cost minimization analysis of radiology versus olive palpation for the diagnosis of hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11115037" id="rid75" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>76 : Is acid base determination an accurate predictor of pyloric stenosis?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23781883" id="rid76" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>77 : Evaluation of hypertrophic pyloric stenosis by pediatric emergency physician sonography.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22295036" id="rid77" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>78 : Accuracy of sonographic criteria in the decision for surgical treatment in infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19308372" id="rid78" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>79 : Pyloric stenosis: role of imaging.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33398405" id="rid79" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>80 : Untwisting the complexity of midgut malrotation and volvulus ultrasound.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33416922" id="rid80" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>81 : Transition to ultrasound as the first-line imaging modality for midgut volvulus: keys to a successful roll-out.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9165317" id="rid81" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>82 : Endoscopic findings in hypertrophic pyloric stenosis: appearance in classic and evolving disease.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7567248" id="rid82" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>83 : Evolving asymmetric hypertrophic pyloric stenosis associated with histologic evidence of eosinophilic gastroenteritis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/5687848" id="rid83" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>84 : Massive bleeding in a newborn infant from a gastric ulcer associated with hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31997530" id="rid84" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>85 : Neonatal eosinophilic gastroenteritis mimicking hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25222812" id="rid85" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>86 : Eosinophilic gastritis with gastric outlet obstruction mimicking infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/13934836" id="rid86" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>87 : Gastric ulcer in the newborn and its association with antral spasm resulting in hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14464627" id="rid87" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>88 : Hypertrophic pyloric stenosis of infancy associated with ulcer. A case report.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8986971" id="rid88" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>89 : Changing patterns of diagnosis and treatment of infantile hypertrophic pyloric stenosis: a clinical audit of 303 patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9785907" id="rid89" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>90 : Hypertrophic pyloric stenosis in infancy. An analysis of treatment outcome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31958865" id="rid90" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>91 : A Delphi Analysis to Reach Consensus on Preoperative Care in Infants with Hypertrophic Pyloric Stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/4757248" id="rid91" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>92 : Congenital hypertrophic pyloric stenosis: the anaesthetist's view.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22225565" id="rid92" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>93 : Hypertrophic pyloric stenosis: it can take your breath away.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16926562" id="rid93" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>94 : Open versus laparoscopic pyloromyotomy for pyloric stenosis: a prospective, randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/19155060" id="rid94" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>95 : Recovery after open versus laparoscopic pyloromyotomy for pyloric stenosis: a double-blind multicentre randomised controlled trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/22244399" id="rid95" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>96 : Pyloromyotomy: randomized control trial of laparoscopic vs open technique.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33686649" id="rid96" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>97 : Open versus laparoscopic pyloromyotomy for pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15978445" id="rid97" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>98 : Pyloromyotomy: a comparison of laparoscopic, circumumbilical, and right upper quadrant operative techniques.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9168087" id="rid98" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>99 : Complications of pyloromyotomy for infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26719292" id="rid99" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>100 : Feeding Post-Pyloromyotomy: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35182200" id="rid100" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>101 : Safety and benefit of ad libitum feeding following laparoscopic pyloromyotomy: retrospective comparative trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24439596" id="rid101" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>102 : Protocol versus ad libitum feeds after laparoscopic pyloromyotomy: a prospective randomized trial.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24952793" id="rid102" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>103 : Risk of incomplete pyloromyotomy and mucosal perforation in open and laparoscopic pyloromyotomy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/18029919" id="rid103" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>104 : Ultrasonographic serial measurements of the morphologic resolution of the pylorus after Ramstedt pyloromyotomy for infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/15923695" id="rid104" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>105 : Oral atropine sulfate for infantile hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/16338303" id="rid105" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>106 : Medical treatment of infantile hypertrophic pyloric stenosis: should we always slice the "olive"?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23378159" id="rid106" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>107 : Is abandonment of nonoperative management of hypertrophic pyloric stenosis warranted?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/23661669" id="rid107" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>108 : Question 2: can a conservative approach to the treatment of hypertrophic pyloric stenosis with atropine be considered a real alternative to surgical pyloromyotomy?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27215474" id="rid108" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>109 : Efficacy of Medical Treatment for Infantile Hypertrophic Pyloric Stenosis: A Meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28701002" id="rid109" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>110 : Atropine Treatment for Hypertrophic Pyloric Stenosis: A Systematic Review and Meta-Analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35305799" id="rid110" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>111 : Current management of pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/6785089" id="rid111" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>112 : Conservative management of infantile pyloric stenosis by nasoduodenal feeding.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/8986998" id="rid112" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>113 : Successful endoscopic balloon dilatation for hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2273424" id="rid113" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>114 : Balloon catheter dilatation for hypertrophic pyloric stenosis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/35577606" id="rid114" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>115 : Controlled long term outcome of pyloromyotomy for pyloric stenosis: No long-term adverse effect.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/10638565" id="rid115" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>116 : Long-term effects of pyloromyotomy on pyloric motility and gastric emptying in humans.</p>
</a>
</div>
</div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
